InnovAge (NASDAQ:INNV) Price Target Cut to $8.00 by Analysts at The Goldman Sachs Group

InnovAge (NASDAQ:INNVFree Report) had its price target decreased by The Goldman Sachs Group from $9.00 to $8.00 in a research note issued to investors on Wednesday, FlyOnTheWall reports.

InnovAge Trading Up 11.8 %

Shares of InnovAge stock opened at $7.59 on Wednesday. InnovAge has a twelve month low of $4.46 and a twelve month high of $8.15. The company has a quick ratio of 1.57, a current ratio of 1.45 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $1.03 billion, a price-to-earnings ratio of -24.48 and a beta of 0.16.

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

See Also

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with's FREE daily email newsletter.